華民股份(300345.SZ):控股子公司取得三級保密資格證書
格隆匯 9 月 8日丨華民股份(300345.SZ)公佈,公司控股子公司湖南紅宇智能製造有限公司(“紅宇智能”)於近日取得湖南國家保密局、湖南省國防科技工業局頒發的《武器裝備科研生產單位三級保密資格證書》。
《武器裝備科研生產單位三級保密資格證書》的取得表明紅宇智能符合《武器裝備科研生產單位保密資格認定辦法》及有關規定要求,是紅宇智能為相關領域提供軍品研發、生產和服務的基礎,是公司獲得的一項重要軍工資質。該證書的獲得為公司拓展軍工領域市場奠定了良好基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.